Pelitrexol, GAR 转化酶抑制剂

CAS: 446022-33-9 货号: P655847 分子式: C20H25N5O6S 分子量: 463.51 PubChem CID: 135431074
有货
级别和纯度: 10mM in DMSO
别名
培利曲索
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
P655847-1ml
期货 Stock Image
¥6,380.90
请输入您要添加的产品数量

概述


Pelitrexol (AG 2037) is an inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), a purine biosynthetic enzyme. Pelitrexol also inhibits mTORC1 by reducing GTP-bound Rheb level, a mTORC1 obligate activator. Pelitrexol shows robust tumor growth suppression in mice

In Vitro

Pelitrexo (150 nM; 24 h) profoundly inhibits mTORC1 activity by reducing intracellular guanine nucleotides level as well as GTP-bound Rheb protein level in A549 cells. Pelitrexo (0-1000 mM; 16 h) strongly inhibits the phosphorylation level of ribosomal protein S6 (S6RP), S6K1, and Chk1 in a dose-dependent manner in NCI-H460 cells. Pelitrexo (100 nM; 48 h) arrests cell cycle at G1 phase in NCI-H460 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cycle AnalysisCell Line: NCI-H460 NSCLC Concentration: 100 nM Incubation Time: 4, 8, 24, 48 hours Result: Resulted 63% cells accumulation in G1 phase of the cell cycle. Cell Cycle AnalysisCell Line: NCI-H460 NSCLC Concentration: 0, 10, 30, 100, 300, 1000 nM Incubation Time: 16 hours Result: Inhibits the level of p-S6RP, p-S6K1, and p-Chk1.

In Vivo

Pelitrexo (10 mg/kg, 20 mg/kg; i.p.; every 4 days for 3 weeks) provokes both mTORC1 inhibition and robust tumor growth suppression in mice bearing nonsmall-cell lung cancer (NSCLC) xenografts . Pelitrexo (20 mg/kg; i.p.; every 4 days for 3 weeks) inhibits GARFT-dependent purine biosynthesis and blocks mTORC1 function . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Xenograft model of nonsmall-cell lung cancer (NSCLC) in mice Dosage: 10 mg/kg, 20 mg/kg Administration: Intraperitoneal injection; every 4 days for 3 weeks for group 1; administrated at 1, 4, 7 days for group 2 Result: Inhibited tumor growth by 64% and 69% at 10 mg/kg and 20 mg/kg, respectively in group 1. Inhibited mTORC1-dependent phosphorylation of S6K1, S6RP and CAD at 20 mg/kg in group 2.

IC50& Target:GARFT

规格

别名
培利曲索
规格或纯度
10mM in DMSO
英文名称
Pelitrexol
生化机理
Pelitrexol (AG 2037) 是嘌呤生物合成酶甘氨核糖核苷酸甲酰转移酶(GARFT)的抑制剂。Pelitrexol 还能通过降低 GTP 结合的 Rheb 水平抑制 mTORC1,Rheb 是 mTORC1 的强制性激活剂。哌立曲醇显示出强大的肿瘤生长能力。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
作用机制
GAR 转化酶抑制剂
名称和识别符
分子类型
小分子
Isomeric SMILES
CC1=C(SC(=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CC[C@H]2CC3=C(NC2)N=C(NC3=O)N
关联CAS
PubChem CID
MeSH Entry Terms
pelitrexol
分子量
463.51

高级数据

产品属性
ALogP 0.7
安全和危险性(GHS)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品应如何储存?
请于?80 °C条件下保存。需超低温保存以维持规定的有效期。
本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 446022-33-9,分子式为 C20H25N5O6S,分子量为 463.51 g/mol。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。